Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Evaluating the impact of an NR1H3 mutation on the reparative properties of microglia and the immunomodulator CD5L in preclinical models of multiple sclerosis
EF 2025-26
Résumé
Multiple sclerosis (MS) is a disease where the body’s immune system attacks nerves in the brain and spinal cord, causing inflammation and disrupting vision, memory, balance, and movement. MS is a leading cause of disability in young adults, and Canada has one of the highest rates worldwide. There is no cure, and current treatments often have serious side effects and do not work well for progressive stages of the disease. Our research aims to understand what drives MS to worsen over time. We developed a mouse model based on a genetic mutation found in families with progressive MS. This gene helps immune cells control inflammation and also plays a role in how cells make and use cholesterol. Cholesterol is a key component of myelin, the fatty sheath that insulates nerves and enables rapid signaling, which is damaged by immune cells in MS. Microglia, the resident immune cells of the central nervous system, normally help repair damage and maintain healthy brain cells. We believe this mutation limits how well cells clear myelin debris and reduces the brain’s ability to make new myelin for repair.
We hypothesize that this mutation impairs microglial repair, leading to chronic inflammation and nerve injury. To test this, we will compare the onset and worsening of disability in mice carrying one or two copies of the mutation versus mice with a normal gene. By studying this model, we aim to uncover key changes that drive MS progression and test strategies to restore microglial repair and control inflammation. We have already shown these mutant mice are missing a key factor needed to slow immune responses, and we think restoring it will support remission. Our ultimate goal is to lay the foundation for better treatments that improve quality of life for people living with MS.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572709
Name
Ho Valerie E
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating the impact of an NR1H3 mutation on the reparative properties of microglia and the immunomodulator CD5L in preclinical models of multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Demyelination; Experimental Autoimmune Encephalomyelitis; Multiple Sclerosis; Neurodegeneration; Neuroimmunology; Neuroinflammation; Neuroprotection
Abstract
Multiple sclerosis (MS) is a disease where the body’s immune system attacks nerves in the brain and spinal cord, causing inflammation and disrupting vision, memory, balance, and movement. MS is a leading cause of disability in young adults, and Canada has one of the highest rates worldwide. There is no cure, and current treatments often have serious side effects and do not work well for progressive stages of the disease. Our research aims to understand what drives MS to worsen over time. We developed a mouse model based on a genetic mutation found in families with progressive MS. This gene helps immune cells control inflammation and also plays a role in how cells make and use cholesterol. Cholesterol is a key component of myelin, the fatty sheath that insulates nerves and enables rapid signaling, which is damaged by immune cells in MS. Microglia, the resident immune cells of the central nervous system, normally help repair damage and maintain healthy brain cells. We believe this mutation limits how well cells clear myelin debris and reduces the brain’s ability to make new myelin for repair.
We hypothesize that this mutation impairs microglial repair, leading to chronic inflammation and nerve injury. To test this, we will compare the onset and worsening of disability in mice carrying one or two copies of the mutation versus mice with a normal gene. By studying this model, we aim to uncover key changes that drive MS progression and test strategies to restore microglial repair and control inflammation. We have already shown these mutant mice are missing a key factor needed to slow immune responses, and we think restoring it will support remission. Our ultimate goal is to lay the foundation for better treatments that improve quality of life for people living with MS.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ho, Valerie E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~